Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Express Scripts To Buy Priority; Will Aetna Buy Out Pharmacy Joint Venture?

Executive Summary

Aetna will consider exercising its option to buy out Priority Healthcare's stake in their specialty pharmacy joint venture following Express Scripts' planned $1.3 bil. acquisition of Priority

You may also be interested in...



Caremark Rejects Express Scripts, Questions M&A History, Strategic Benefit

Caremark is highlighting Express Scripts' "questionable" record integrating prior acquisitions in trying to convince investors to support its proposed merger with pharmacy chain CVS

Caremark Rejects Express Scripts, Questions M&A History, Strategic Benefit

Caremark is highlighting Express Scripts' "questionable" record integrating prior acquisitions in trying to convince investors to support its proposed merger with pharmacy chain CVS

Cost Containment For Specialty Products Is New Horizon For PBMs

Rising spending on specialty pharmaceuticals is creating a major business opportunity for pharmacy benefit managers, despite the sector's historical cost containment challenges

Related Content

Topics

UsernamePublicRestriction

Register

PS046141

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel